deaths (OS)progression or deaths (PFS)RFS/DFS

endometrial cancer endometrial cancer

versus doxorubicin
pembrolizumab plus lenvatinib vs. doxorubicin 1 NaN [NaN; NaN] /10000
0/0 vs. 0/0
NaN [NaN; NaN] /10000
0/0 vs. 0/0
-